Go to Client Portal
NAMSA

NAMSA EXPANDS MEDTECH PORTFOLIO IN MARKET INTELLIGENCE AND CUSTOMER RESEARCH SERVICES THROUGH ITS ACQUISITION OF EU-BASED SUAZIO

 

 

 

TOLEDO, OHIO and ANTWERP, BELGIUM – BUSINESSWIRE—MARCH 27, 2023NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of SUAZIO, an EU-based strategic consultancy providing global market research services to medical device and IVD developers.

Founded in 2001 in Antwerp, Belgium, SUAZIO’s mission is to provide market insights to the MedTech industry across the globe through its data, people and analytics solutions. The organization develops custom frameworks for each Client based on specific market needs, technology value drivers, patient journeys, digital healthcare environment and economic value proposition. Keeping each stakeholder’s perspective in mind, this research results in robust data and accurate interpretation leading to clear recommendations and strategies for successful market introduction.

NAMSA’s other consulting services include: Biological Safety, Quality, Regulatory, Reimbursement and Product Development Strategy. These teams are led by the MedTech industry’s foremost experts, many of whom have held positions with the U.S. Food and Drug Administration (FDA), EU Notified Bodies and APAC authorities. NAMSA Consultants, who communicate with global government entities daily, are uniquely qualified to provide wide-ranging consulting services across the product development spectrum. NAMSA’s proven services and outcomes ultimately allow Clients to get to market faster and make a more immediate impact on patient safety and global healthcare.

The acquisition of SUAZIO increases NAMSA’s global presence to 20 locations across the Americas, Asia and Europe.

The price and terms of the transaction are undisclosed.

Leah Davidson, MA, MBA, PCM

Leah Davidson, MA, MBA, PCM

Leah has been with NAMSA since 2016 and currently serves as Senior Manager of Global Marketing Communications. She possesses nearly 25 years' experience within the medical device and healthcare technology industries and has worked in various marketing and communications capacities throughout her career. In her role at NAMSA, she is responsible for the development and implementation of brand strategies and marketing communications initiatives that help drive the organization's sales and organizational growth goals globally.